vahideh aghamohammadi

Dr. vahideh aghamohammadi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ESEsmail Shoja
Esmail Shoja
VAvahideh aghamohammadi
vahideh aghamohammadi
HBHadi Bazyar
Hadi Bazyar
HMHamed Rezakhani Moghaddam
Hamed Rezakhani Moghaddam
KNKhadijeh Nasiri
Khadijeh Nasiri
AAAmin Asgari
Amin Asgari
Background: In this study, we aimed to evaluate the impact of the COVID-19 epidemic on the workload and mental health of Iranian medical staff using the General Health Questionnaire (GHQ-12) and NASA -Task Load Index (NASA-TLX) Questionnaire between March and April 2020, respectively. Methods: The present cross-sectional study was conducted from March 5th to April 5th, 2020. To evaluate the workload and mental health of participants NASA-TLX and GHQ-12 online questionnaires were distributed. Data were entered into software SPSS (Version 23) and T-test, ANOVA, Regression methods were used for data analysis. Results: Health workers who encountered COVID- 19 patients, were subjected to more task load compared to those who had no contact with COVID- 19 patients at the workplace (p < 0.001). In terms of the subscale score of NASA-TLX, nurses had more scores in mental pressure, physical pressure, time pressure (temporal), and frustration compared to the other jobs (p < 0.05). Moreover, nurses had significantly more workload compared to the other jobs. Conclusions: Type of job, the shift of work, educational level, and facing COVID-19 affected the score of NASA-TLX. NASA-TLX scores were higher in nursing compared to the scores of other health staff groups. The results of this study indicate that the scores of NASA-TLX and GHQ-12 among staff who had contact with COVID-19 patients were significantly higher than those who did not face COVID-19 patients. We suggested that a comprehensive assistance should be provided to support the well-being of healthcare workers especially nurses and healthcare workers who treated COVID-19 patients.

3 August 2023 in Frontiers in Nutrition
Verified
Journal Article
Open access
HBHadi Bazyar
Hadi Bazyar
AJAhmad Zare Javid
Ahmad Zare Javid
AAAkram Ahangarpour
Akram Ahangarpour
FZFerdows Zaman
Ferdows Zaman
SHSeyed Ahmad Hosseini
Seyed Ahmad Hosseini
MCMohammad Ghasemi Deh Cheshmeh
Mohammad Ghasemi Deh Cheshmeh
Background: This trial aimed to investigate the effects of rutin supplement in type 2 diabetes mellitus (T2DM) patients.Methods: In this trial with a double-blind and controlled design, fifty patients were randomly divided into intervention (n = 25) and control groups (n = 25) and were treated with 1 g of rutin or placebo for three months, respectively. At the baseline and end of the intervention, mean arterial pressure (MAP), heart rate (HR), pulse pressure (PP), systolic and diastolic blood pressure (SBP and DBP), serum levels of antioxidant enzymes, such as catalase (CAT), glutathione peroxidase (GPx), and superoxide dismutase (SOD) and quality of life (QOL) parameters, were evaluated.Results: Rutin consumption caused a significant reduction in SBP, DBP, PP, MAP, and HR, with a significant increase in SOD, CAT, and GPx and some QOL parameters (emotional limitations, energy and freshness, mental health, social performance, and general health) compared with baseline (p for all <0.05). Also, the mean changes of emotional limitations, energy and freshness, mental health, and general health (unadjusted p for all <0.05) and GPX and SOD (adjusted p for all <0.05) were significantly higher in the rutin group compared with the placebo group. Although, in the supplement group compared with the placebo group, the mean changes of SBP, DBP, MAP, PP, and HR were significantly lower (adjusted p for all <0.05).Conclusion: Rutin consumption improved blood pressure, the levels of antioxidant enzymes, and QOL in patients with T2DM.

18 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HBHadi Bazyar
Hadi Bazyar
AJAhmad Zare Javid
Ahmad Zare Javid
MMMahmood Reza Masoudi
Mahmood Reza Masoudi
FHFatemeh Haidari
Fatemeh Haidari
ZHZeinab Heidari
Zeinab Heidari
MVMahdi Vajdi
Mahdi Vajdi
Limited research has explored the effectiveness of insulin resistance (IR) in forecasting metabolic syndrome (MetS) risk, especially within the Iranian population afflicted with type 2 diabetes mellitus (T2DM). The present investigation aimed to assess the efficacy of IR indices in predicting the risk of MetS among T2DM patients. Convenient sampling was utilized to select four hundred subjects with T2DM. Metabolic factors and IR indices, including the Waist Circumference-Triglyceride Index (WTI), Triglyceride and Glucose Index (TyG index), the product of TyG index and abdominal obesity indices, and the Metabolic Score for Insulin Resistance (METS-IR), were evaluated. Logistic regression, coupled with modeling, was employed to explore the risk of MetS. The predictive performance of the indices for MetS stratified by sex was evaluated via receiver operating characteristic (ROC) curve analysis and estimation of the area under the curve (AUC) values. The TyG-Waist Circumference (TyG-WC) index exhibited the largest AUCs in both males (0.91) and females (0.93), while the TyG-Body Mass Index (TyG-BMI) demonstrated the smallest AUCs (0.77 in males and 0.74 in females). All indices significantly predicted the risk of MetS in all subjects before and after adjustment (p < 0.001 for all). The TyG-WC index demonstrated the highest odds ratios for MetS (8.06, 95% CI 5.41–12.00). In conclusion, all IR indices assessed in this study effectively predicted the risk of MetS among Iranian patients with T2DM, with the TyG-WC index emerging as the most robust predictor across both genders.

1 February 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
HBHadi Bazyar
Hadi Bazyar
AJAhmad Zare Javid
Ahmad Zare Javid
HBHossein Bavi Behbahani
Hossein Bavi Behbahani
NSNitin Shivappa
Nitin Shivappa
JHJames R. Hebert
James R. Hebert
VAvahideh aghamohammadi
vahideh aghamohammadi

17 July 2020 in Trials
Verified
Journal Article
Open access
PDF file
FHFatemeh Haidari
Fatemeh Haidari
VAvahideh aghamohammadi
vahideh aghamohammadi
MMMajid Mohammadshahi
Majid Mohammadshahi
KAKambiz Ahmadi-Angali
Kambiz Ahmadi-Angali
MAMohammad Asghari-Jafarabadi
Mohammad Asghari-Jafarabadi
Background: Despite the importance of dairy proteins in modifying of metabolic abnormalities, no attention has been given to their effects on endocannabinoids. Methods: A total number of 60 obese women were recruited in a 2-month randomized clinical trial. Following random allocation, they were assigned to one of the two groups: control (n = 30) and intervention (n = 30). Then, all the subjects followed a hypocaloric diet of 800 kcal below estimated energy needs. The intervention group received isocaloric weight-loss diet and whey protein powders (30 g/day). Baseline and 2-month fasting anthropometric, blood glucose, serum insulin, insulin resistance, lipid profile, AEA, and 2-AG were measured. Results: The study groups were homogenous in terms of baseline characteristics (p > 0.05) except for MUFA intake (p = 0.021). There were no significant differences in energy and macronutrient intakes in the intervention group compared to the control group at the end of the study (p > 0.05). The results of the ANCOVA did not show significant reductions in body weight and BMI of the intervention group compared to the control group (p > 0.05); however, WC, body fat, FBS, AEA, 2-AG, total cholesterol, and triglyceride decreased and HDL-c significantly increased in the intervention group compared to the control group (p < 0.05). Conclusions: In this study, the effects of simultaneous weight-loss diet and whey protein supplementation on the reduction of endocannabinoids were determined. Trial registration: Iranian Registry of Clinical Trials IRCT2017021410181N8. Registered on March 2017.

1 January 2020 in International Journal of Nursing Sciences
Verified
Journal Article
Open access
MAMercedeh Masoumi Alamout
Mercedeh Masoumi Alamout
MRMahdieh Rahmanian
Mahdieh Rahmanian
VAvahideh aghamohammadi
vahideh aghamohammadi
EMElahe Mohammadi
Elahe Mohammadi
KNkhadijeh Nasiri
khadijeh Nasiri
Prevalence rates of overweight and obesity are dramatically ever-increasing across the world. Therefore, this study was to evaluate the effect of mindfulness-based cognitive therapy (MBCT) on weight loss, hypertension, and attentional bias towards food cues in a group of women affected with this condition. A total of 45 participants were selected out of women referring to the Nutrition and Diet Therapy Clinic affiliated to Shahid Beheshti University of Medical Sciences, Iran, and then randomized into three groups of 15. The first experimental group was subjected to an energy-restricted diet therapy together with MBCT during 8 sessions, the second group took the diet therapy alone, and the third group received no intervention. Body mass index (BMI), hypertension, and attentional bias towards food cues were correspondingly evaluated before, at the end, and four weeks after the completion of the interventions. The results of this study revealed that MBCT, along with diet therapy, had been significantly more effective in weight loss, decrease in BMI, lower systolic blood pressure (SBP), and attentional bias towards food cues compared with the diet therapy alone (P ≤ 0.01). MBCT had no significant impact on the decline in diastolic blood pressure (DBP) in participants in the follow-up phase. This study demonstrated that MBCT along with the conventional diet therapy was more effective in weight loss, decrease in BMI, hypertension control, as well as attentional bias towards food cues than the diet therapy alone.